Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-16

Clinical Trial Update: A Mechanism Based Proof of Concept Study of the Effects of Duloxetine in the Treatment of Patients With Osteoarthritic Knee Pain [Phase 2]

View source ↗

Summary

Phase 2 mechanistic proof-of-concept study evaluating duloxetine for osteoarthritic knee pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Kristian Kjær Petersen | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED